Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
Surv Ophthalmol ; 69(2): 211-223, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-37944600

RESUMEN

Polyvinyl pyrrolidone or povidone-iodine (PVP-I) is a water-soluble complex formed by the combination of iodine and a water-soluble polymer, polyvinyl pyrrolidone. This complex exerts bactericidal, fungicidal, and virucidal action by gradually releasing free iodine at the site of application to react with pathogens. In ophthalmology, PVP-I is used as a disinfectant and antiseptic agent for preoperative preparation of the skin and mucous membranes and for treating contaminated wounds. PVP-I has been shown to reduce effectively the risk of endophthalmitis in various ocular procedures, including cataract surgery and intravitreal injections; however, it has also been used in the treatment of conjunctivitis, keratitis, and endophthalmitis, with promising results especially in low-resource situations. PVP-I has been associated with complications such as postoperative eye pain, persistent corneal epithelial defects, ocular inflammation, and an attendant risk of keratitis. In cases of poor PVP-I tolerance, applying PVP-I at lower concentrations or using alternative antiseptics such as chlorhexidine should be considered. We provide an update on the efficacy of PVP-I in the prophylaxis and treatment of conjunctivitis, keratitis, and endophthalmitis and a comprehensive analysis of the current literature regarding the use of PVP-I in the management of these ocular conditions. Also, PVP-I-related adverse effects and toxicities and its alternatives are discussed. The goal is to present a thorough evaluation of the available evidence and to offer practical recommendations for clinicians regarding the therapeutic usage of PVP-I in ophthalmology.


Asunto(s)
Antiinfecciosos Locales , Extracción de Catarata , Conjuntivitis , Endoftalmitis , Yodo , Queratitis , Oftalmología , Humanos , Povidona Yodada/farmacología , Povidona Yodada/uso terapéutico , Polivinilos , Antiinfecciosos Locales/farmacología , Antiinfecciosos Locales/uso terapéutico , Yodo/uso terapéutico , Endoftalmitis/tratamiento farmacológico , Endoftalmitis/prevención & control , Povidona , Conjuntivitis/inducido químicamente , Conjuntivitis/tratamiento farmacológico , Queratitis/tratamiento farmacológico , Agua
2.
J Cataract Refract Surg ; 50(7): 760-766, 2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38350230

RESUMEN

Ocular trauma is an important cause of monocular blindness worldwide. Injury to the lens after blunt or penetrating trauma is common and can result in vision impairment. Selecting the most appropriate therapeutic approaches depends on factors such as patients' age, mechanism of trauma, and underlying clinical conditions. Early management, especially within childhood, is essential because of the difficulties involved in examination; anatomical variations; as well as accompanying intraocular inflammation, amblyopia, or vitreoretinal adhesions. The objective of this study was to provide a comprehensive review of the epidemiology and clinical management of traumatic cataract, highlighting the significance of accurate diagnosis and selection of the optimal therapeutic approach.


Asunto(s)
Catarata , Lesiones Oculares , Cristalino , Humanos , Catarata/etiología , Lesiones Oculares/etiología , Lesiones Oculares/complicaciones , Lesiones Oculares/diagnóstico , Cristalino/lesiones , Heridas no Penetrantes/complicaciones , Heridas no Penetrantes/diagnóstico , Extracción de Catarata
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA